Core Viewpoint - The company, Zhejiang Zhuojin Environmental Technology Co., Ltd., has announced the use of its own funds to pay personnel costs for fundraising projects and will replace these amounts with raised funds, ensuring compliance with regulations and maintaining operational efficiency [7][9][12]. Financial Data - The company reported that the total amount raised from its initial public offering was RMB 251.099 million, with a net amount of RMB 200.792 million after deducting issuance costs [7]. - The company has implemented a special account management system for the raised funds, ensuring that all expenditures are made from this account [7]. Fund Usage - The company has decided to conclude the "Enterprise Technology R&D Center Project" and redirect surplus funds from the "Branch Construction Project" to the "Industrial Three Wastes Comprehensive Treatment and Resource Utilization R&D Project" [8]. - The company plans to use its own funds to cover personnel costs during the implementation of fundraising projects, which will later be replaced with raised funds to comply with banking regulations [9][10]. Approval Process - The decision to use self-owned funds for personnel costs and subsequently replace them with raised funds was approved by the company's board and audit committee [11][12]. - The sponsor institution has reviewed and agreed that this arrangement does not affect the normal implementation of fundraising projects and complies with relevant regulations [12][13].

Core Viewpoint - The company, Zhejiang Zhongxin Environmental Technology Group Co., Ltd., is undertaking significant corporate actions including the absorption merger of its wholly-owned subsidiaries and the management of idle funds to enhance operational efficiency and shareholder returns [9][15][70]. Financial Data - The company reported that its third-quarter financial statements are unaudited, and it has provided key financial data and indicators for the period [3][7]. - The company has adjusted previous financial figures, reducing management expenses by 2,300,321.67 yuan and increasing sales and R&D expenses [6]. Shareholder Information - The company has confirmed that there are no changes in the major shareholders or their shareholding status due to the proposed actions [5][11]. Cash Management - The company plans to use up to 30 million yuan of temporarily idle raised funds for cash management, focusing on low-risk, high-liquidity financial products [16][21]. - The cash management will be valid for 12 months and can be rolled over within this period [21][31]. Merger and Restructuring - The company has approved the absorption merger of its wholly-owned subsidiaries, aiming to optimize management structure and reduce costs [9][10]. - The merger does not constitute a related party transaction or a significant asset restructuring as per regulatory definitions [9]. Risk Management - The company has established risk control measures for its cash management and foreign exchange derivative trading, ensuring compliance with relevant regulations and safeguarding shareholder interests [28][63]. Upcoming Shareholder Meeting - The company has scheduled a second extraordinary general meeting for shareholders on November 18, 2025, to discuss various proposals including the foreign exchange derivative trading business [88].

Core Viewpoint - The company has effectively managed its idle raised funds by temporarily supplementing working capital and has returned the full amount to the designated account within the stipulated time frame, demonstrating compliance with regulatory requirements and internal financial management policies [1][2]. Group 1: Fund Management - On October 29, 2024, the company announced the return of 290 million yuan of idle raised funds to the designated account, which was previously used to temporarily supplement working capital [1]. - The board approved the use of up to 290 million yuan of idle raised funds for working capital, with a usage period not exceeding 12 months from the date of approval [1]. - The company has returned the full amount of 290 million yuan to the designated account by October 28, 2025, without exceeding the usage period and without any overdue situations [1]. Group 2: Financial Efficiency - The return of funds reflects the company's commitment to the regulated management of raised funds, enhancing fund utilization efficiency while adhering to usage agreements [2]. - The rational use of idle raised funds to supplement working capital is seen as beneficial for optimizing cash flow structure and reducing financial costs [2]. - Timely and full repayment of the funds further emphasizes the company's prudent attitude towards financial management [2].

Core Points - Jiangsu Hongwei Technology Co., Ltd. has fully repaid the idle raised funds of 6 million yuan used for temporary liquidity support, complying with regulatory requirements [1][2] Group 1: Fund Usage and Repayment - The company held a board meeting on October 30, 2024, approving the use of 6 million yuan of idle raised funds for liquidity support related to its main business, with a usage period of 12 months [2] - The funds were sourced from the company's initial public offering (IPO) in 2021, with the initial receipt date being August 27, 2021 [2] - The full repayment of the 6 million yuan was completed on October 27, 2025, with no overdue situation reported [2] Group 2: Management and Compliance - The proper use and timely repayment of the idle raised funds reflect the company's prudent attitude towards fund management, enhancing fund efficiency while ensuring safety [2] - The company commits to continue adhering to the Shanghai Stock Exchange's regulations and its own fund management policies to ensure that the fund usage aligns with the intended purposes [2]

Core Points - The company held its 19th meeting of the 6th Board of Directors on October 27, 2025, where several resolutions were passed regarding the management and utilization of raised funds [2][3][5]. Group 1: Fund Management and Utilization - The company approved the establishment of a special account for raised funds and signed a tripartite/four-party supervision agreement for fund storage [3]. - The company decided to adjust the actual investment amount of raised funds for specific projects in 2023 [4]. - The company will use part of the idle raised funds for cash management, with a limit of up to 200 million yuan [38]. Group 2: Fund Allocation to Subsidiaries - The company approved the use of raised funds to increase capital or provide loans to its wholly-owned subsidiary, Jiangxi Brother Pharmaceutical Co., Ltd., for project implementation [10][11]. - The total amount allocated for this purpose is 42,824.88 million yuan, which includes net interest income and financial gains [11][12]. Group 3: Fund Replacement and Reimbursement - The company will replace pre-invested self-raised funds and paid issuance expenses with raised funds, totaling 222,647,327.66 yuan [20][21]. - The company will ensure that the replacement of funds does not affect the normal implementation of the investment projects [22][23]. Group 4: Project Timeline and Adjustments - The company announced a delay in the project timeline for the "Annual Production of 600 Tons of Iodinated Contrast Agent Construction Project" to September 2026 [56][57]. - This delay is due to the later-than-expected arrival of raised funds, which has slowed the investment progress [57].

Group 1 - The company guarantees the authenticity, accuracy, and completeness of the information disclosed in its announcements [1][2] - The board of directors and senior management confirm the financial report's authenticity and completeness, assuming legal responsibility [2][3] - The third-quarter financial report has not been audited [3][7] Group 2 - The company plans to provide a guarantee of up to RMB 17.58 million for its subsidiary's credit application [8][15] - The board approved the guarantee proposal with a unanimous vote, and the chairman recused himself from the vote due to a conflict of interest [9][18] - The guarantee is deemed fair and does not harm the company's interests [18][19] Group 3 - The company has completed several fundraising projects and plans to permanently supplement its working capital with surplus funds amounting to RMB 183.25 million [61][67] - The fundraising projects have met the conditions for completion, and the funds will be used for daily operations and business development [61][67] - The decision to supplement working capital is based on the company's operational needs and is expected to improve fund utilization efficiency [67][70] Group 4 - The company will hold its second extraordinary general meeting of 2025 on November 12, 2025, to discuss various proposals [25][28] - The meeting will combine on-site voting and online voting, with specific time slots for each [28][29] - Shareholders must register by November 6, 2025, to participate in the meeting [30][38]

二、归还募集资金的相关情况 莱克电气股份有限公司关于归还临时补充流动资金的募集资金的公告 ● 截至2025年10月27日，公司已累计归还临时补充流动资金的闲置募集资金人民币20,000万元。 一、募集资金临时补充流动资金情况 莱克电气股份有限公司（以下简称"公司"）于2024年10月28日召开的第六届董事会第十四次会议和第六 届监事会第十次会议，审议通过了《关于使用闲置募集资金暂时补充流动资金的议案》。在确保募集资 金项目建设的资金需求以及募集资金使用计划正常进行的前提下，同意公司及子公司使用不超过30,000 万元的闲置募集资金暂时补充流动资金，使用期限为自董事会审议通过之日起不超过12个月。监事会、 保荐机构已对上述事项发表明确同意的意见。具体情况详见公司于2024年10月29日在上海证券交易所网 站（www.sse.com.cn）披露的《莱克电气股份有限公司关于使用闲置募集资金暂时补充流动资金的公 告》（公告编号：2024-063）。 自公司第六届董事会第十四次会议审议通过后，公司及子公司实际使用20,000万元闲置募集资金补充流 动资金。公司严格按照中国证监会《上市公司募集资金监管规则》和《上海证券交 ...

Core Viewpoint - Hansan (Nanjing) Technology Co., Ltd. held its fifth meeting of the second board of directors on October 24, 2025, where several important resolutions were passed, including the approval of the Q3 2025 report and adjustments to the investment amounts of raised funds, laying a foundation for the company's future operational development and proper use of raised funds [1][3][4]. Group 1: Board Meeting Overview - The board meeting was convened on October 24, 2025, with all nine directors present, including one participating via communication [2]. - The meeting was legally valid, following the procedures outlined in the Company Law and the Articles of Association [2]. Group 2: Resolutions Passed - Resolution 1: The Q3 2025 report was approved unanimously, confirming that the report complies with legal regulations and accurately reflects the company's situation [3]. - Resolution 2: The board approved adjustments to the investment amounts for fundraising projects, ensuring that any shortfall will be covered by self-owned or self-raised funds without harming shareholder interests [4]. - Resolution 3: The board agreed to use raised funds to replace previously invested self-raised funds, confirming compliance with relevant regulations and ensuring that the investment plan remains unaffected [5]. Group 3: Implications for the Company - The approval of these resolutions is expected to further standardize the company's information disclosure and fundraising management, providing assurance for future operational development [5].

Core Viewpoint - Changchun Baike Biological Technology Co., Ltd. plans to deposit a maximum of RMB 150 million of temporarily idle raised funds in fixed-term deposits to enhance fund utilization efficiency and increase returns for the company and its shareholders [1][3][4]. Fundraising Basic Situation - The company raised a total of RMB 1,500,675,944.50 through the public offering of 41,284,070 shares at a price of RMB 36.35 per share, with a net amount of RMB 1,395,794,418.15 after deducting various fees [1][2]. Purpose of Fund Deposit - The purpose of depositing the idle funds is to improve the efficiency of fund usage while ensuring that it does not affect the implementation of investment projects and the safety of the raised funds [3][4]. Deposit Details - The maximum amount to be deposited is RMB 150 million, with a usage period from October 24, 2025, to April 23, 2026, allowing for rolling use within this timeframe [4][6]. Implementation and Management - The board of directors has authorized the chairman or designated personnel to sign relevant legal documents, with the finance department responsible for organizing the implementation [6][9]. Information Disclosure - The company will comply with relevant regulations and timely fulfill information disclosure obligations, ensuring that the purpose of the raised funds remains unchanged [7][8]. Impact on Daily Operations - The plan to deposit idle funds will not affect the normal operation of the company's daily funds or the implementation of investment projects, ensuring no harm to the interests of the company and its shareholders [9][10]. Decision-Making Process - The board of directors approved the proposal during the ninth meeting of the sixth board on October 23, 2025, without needing to submit it to the shareholders' meeting [11][12].

Core Viewpoint - The company has released its third-quarter financial report, highlighting significant changes in key financial metrics and the reasons behind these changes. Financial Data Summary - Cash and cash equivalents increased by 856,376,042.71 yuan, a growth of 122.62%, primarily due to product sales and redemption of financial products [5] - Trading financial assets decreased by 3,212,488,586.20 yuan, a decline of 65.82%, mainly due to the redemption of structured deposits [5] - Accounts receivable increased by 3,953,257,495.43 yuan, a rise of 162.61%, attributed to the implementation of annual credit sales policies [5] - Short-term borrowings decreased by 220,225,698.88 yuan, a drop of 72.63%, due to repayment of loans by subsidiaries [6] - Other comprehensive income increased by 19,462,502.95 yuan, a growth of 498.39%, due to foreign currency translation differences from overseas subsidiaries [8] Profit and Loss Summary - Financial expenses decreased by 37,675,740.67 yuan, a decline of 59.09%, due to reduced interest-bearing liabilities and financing costs [10] - Investment income decreased by 33,418,407.38 yuan, a drop of 59.72%, due to a reduction in matured financial products and debt restructuring income [10] - Operating expenses decreased by 32,856,448.26 yuan, a decline of 84.09%, due to reduced losses from non-current asset write-offs [10] Cash Flow Summary - Net cash flow from operating activities decreased by 1,167,228,139.90 yuan, a decline of 43.13%, primarily due to changes in cash inflows from sales and the impact of previous consolidations [12] - Net cash flow from investing activities increased by 2,613,154,808.08 yuan, a growth of 914.44%, due to reduced cash outflows from subsidiaries [12] - Net cash flow from financing activities decreased by 1,028,589,459.64 yuan, a decline of 51.68%, due to reduced net borrowings and increased payments for equity investments [12] Shareholder Information - The company reported no changes in the number of shareholders or significant changes in the top ten shareholders [14] Other Important Matters - The company is involved in ongoing litigation related to quality issues with gypsum board products, with most cases settled, but one case still pending [15] - The company has engaged in wealth management activities, purchasing structured deposits totaling 490 million yuan during the reporting period [16]